CYTK - Cytokinetics, Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents42,256125,20666,87465,076
Short Term Investments156,475143,68589,37546,366
Net Receivables6,7851,11224212
Inventory----
Other Current Assets----
Total Current Assets207,674274,295158,633113,107
Long Term Investments-16,5187,672179
Property Plant and Equipment3,2043,5683,6371,751
Goodwill----
Intangible Assets----
Accumulated Amortization----
Other Assets300429200200
Deferred Long Term Asset Charges----
Total Assets211,178294,810170,142115,237
Current Liabilities
Accounts Payable3,7645,2534,2362,238
Short/Current Long Term Debt2,607-2,500-
Other Current Liabilities669,7999,14720,990
Total Current Liabilities22,19432,44433,25831,649
Long Term Debt39,80631,77727,38114,639
Other Liabilities123,244120,74715,142359
Deferred Long Term Liability Charges----
Minority Interest----
Negative Goodwill----
Total Liabilities185,244184,96875,78146,647
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock55544140
Retained Earnings-743,324-646,081-518,291-534,744
Treasury Stock500343137149
Capital Surplus768,703755,526612,474603,145
Other Stockholder Equity500343137149
Total Stockholder Equity25,934109,84294,36168,590
Net Tangible Assets25,934109,84294,36168,590